DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Cubist Pharmaceuticals (NASDAQ: CBST)

75.65 0.69 (0.92%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CBST $75.65 0.92%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $75.18
Previous Close $74.96
Daily Range $74.69 - $75.99
52-Week Range $58.50 - $82.12
Market Cap $5.8B
P/E Ratio 91.41
Dividend (Yield) $0.00 (0.0%)
Volume 294,515
Average Daily Volume 707,579
Current FY EPS $1.51

Sector

Healthcare

Industry

Drugs

Cubist Pharmaceuticals (CBST) Description

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Website: http://www.cubist.com/

News & Commentary

3 Fast-Growing Biotech Stocks To Buy in December

You don't want to miss out on these tiny biotechs expected to see earnings grow sharply in 2015.

Cempra Poised To Join Antibacterial Drug Acquisition Buzz With Upcoming Data Release

Top Analyst Upgrades and Downgrades: AmEx, Apache, Cliffs, Denbury, JetBlue, Synchrony and More

UPDATE: Credit Suisse Downgrades Cubist Pharmaceuticals On Execution Risk To Global Expansion Of Hos

UPDATE: Credit Suisse Downgrades Cubist Pharmaceuticals On Execution Risk To Global Expansion Of Hospital Franchise

5 Things Actavis plc's Management Wants You to Know

Specialty and generic drugmaker Actavis plc reported another monster quarter last week. Here are five things management wants investors to know going forward.

Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy

Wedbush Initiates Coverage On Cubist Pharmaceuticals

Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog

Why We Think Cubist Pharmaceuticals Has Incredible Upside

3 States With the Worst Hospital Infection Rates

According to CDC data, these states have the largest percentage of hospitals that are failing to meet their benchmarks; here's what the government is doing about it.

See More CBST News...

CBST's Top Competitors

CBST $75.65 (0.92%)
Current stock: CBST
BIIB $304.92 (-0.16%)
Current stock: BIIB
AMGN $164.72 (1.53%)
Current stock: AMGN
CELG $112.61 (1.39%)
Current stock: CELG